CraniUS Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- CraniUS Therapeutics's estimated annual revenue is currently $5.6M per year.
- CraniUS Therapeutics's estimated revenue per employee is $266,667
- CraniUS Therapeutics's total funding is $19M.
Employee Data
- CraniUS Therapeutics has 21 Employees.
- CraniUS Therapeutics grew their employee count by -28% last year.
CraniUS Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CTO/CPO | Reveal Email/Phone |
2 | VP, Strategy & Operations | Reveal Email/Phone |
3 | Senior Director Systems Engineering | Reveal Email/Phone |
4 | Senior Director Product Development and Manufacturing | Reveal Email/Phone |
5 | Senior Director Engineering | Reveal Email/Phone |
6 | Quality Engineering Manager | Reveal Email/Phone |
CraniUS Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $180M | 378 | 5% | N/A | N/A |
#2 | $1.7M | 44 | 2% | N/A | N/A |
#3 | $125.2M | 263 | 4% | N/A | N/A |
#4 | $0.2M | 5 | 0% | N/A | N/A |
#5 | $7.5M | 87 | 32% | N/A | N/A |
#6 | $7.5M | 122 | 28% | N/A | N/A |
#7 | $2.5M | 11 | 10% | N/A | N/A |
#8 | $7.5M | 39 | -15% | $78.9M | N/A |
#9 | $5.6M | 21 | -28% | $19.4M | N/A |
#10 | $16.4M | 48 | 45% | N/A | N/A |
What Is CraniUS Therapeutics?
CraniUS' mission is to invent and engineer world-class technology to define the future of diagnostics and treatments for neurosurgical patients with brain disease.\n\nCAUTION – The NeuroPASS device is an investigational device limited by Federal (or United States) law to investigational use and is not available for commercial distribution.
keywords:N/A
$19M
Total Funding
21
Number of Employees
$5.6M
Revenue (est)
-28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Baltimore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.6M | 21 | 62% | N/A |
#2 | $4.3M | 21 | -25% | N/A |
#3 | $4M | 21 | -12% | N/A |
#4 | $1.5M | 21 | 11% | $2.3M |
#5 | $3.3M | 21 | 5% | N/A |